Target intelligence / Profile preview

Immediate early gene expression, including FosB (IEG)

Target
IEG
Molecular classification
Transcription factors, Immediate early genes, Proto-oncogenes, Activity-dependent genes
01

Overview

Immediate early genes represent a class of genes that are rapidly and transiently induced in response to cellular stimuli, independent of protein synthesis. These genes are expressed within minutes of neuronal activity triggered by environmental stimuli and serve as critical mediators between external signals and long-term changes in cellular function. The Fos family, including FosB, c-Fos, Fra-1, and Fra-2, are proto-oncogenes that encode transcription factors. FosB is particularly notable for producing ΔFosB, a stable splice variant that lacks the C-terminal degron domain and persistently accumulates after chronic stimulation. This stability is enhanced by CAMKIIα phosphorylation at Ser37. c-Fos encodes a 380 amino acid, 62 kDa protein with a basic leucine zipper region for dimerization and DNA-binding, plus a C-terminal transactivation domain. It forms heterodimers with c-Jun to create the AP-1 complex, which binds specific DNA sequences to regulate target gene expression. Various stimuli including serum, growth factors, tumor promoters, cytokines, and UV radiation induce expression within 15 minutes. In the nervous system, immediate early genes play fundamental roles in myelination, vascularization, learning and memory, and synaptic plasticity. They are activated downstream of NMDA receptors and growth factors. The protein products can function as transcription factors (c-Fos, Egr family) or effector proteins (Arc) that directly influence cellular function. The involvement in both normal physiology and disease pathology, combined with context-dependent effects, makes immediate early gene expression a complex biological process rather than a straightforward therapeutic target.

Other names
c-Fosc-fosFosBΔFosBdelta FosBc-JunEgr1Early growth response 1Egr3Early growth response 3Arc/Arg3.1Fra-1Fra-2Fos-related antigens
02

Mechanism of action

Rather than being drug targets themselves, immediate early genes function through several mechanisms: FosB protein dimerizes with Jun family proteins to form AP-1 (Activator Protein-1) transcription factor complex. AP-1 binds DNA at specific promoter and enhancer regions to regulate target gene expression. c-Fos expression is stimulated by cAMP and Ca²⁺ through CREB/CRE complex activation. ΔFosB regulates genes including GluR2, CAMKIIα, and influences G9a repressive histone methylation. Posttranslational modifications by kinases (MAPK, CDC2, PKA, PKC) regulate protein stability and DNA-binding activity.

03

Biological functions

Signal transduction - converting extracellular signals into changes in gene expressionNeuronal activity marking - rapidly and transiently induced within 15 minutes of stimulationMemory formation and synaptic plasticity - critical for encoding environmental experiencesCell proliferation and survivalCell differentiationRegulation of downstream target genes (late-response genes)Structural plasticity - including dendritic spine formation
04

Disease associations

Cancer - c-Fos overexpression associated with osteosarcoma, endometrial carcinoma, breast cancer, and cervical cancerAddiction - ΔFosB accumulation in striatal neurons promotes psychostimulant addiction and cocaine-seeking behaviorsNeurodegenerative disease - implicated in Alzheimer's disease pathwaysPsychiatric disorders - particularly schizophrenia, where Egr family genes mediate genetic and environmental influences
05

Safety considerations

Dual oncogenic and tumor-suppressor activity - c-Fos can both promote and suppress tumorigenesis depending on cellular contextTissue-specific effects - transgenic mice lacking c-Fos are viable but display developmental defects including osteoporosis, delayed gametogenesis, lymphopenia, and behavioral abnormalitiesContextual dependency - effects depend on dimerization partners, co-activators, and promoter architectureRapid and transient expression - makes therapeutic intervention timing challenging
06

Biomarkers

c-Fos and Egr1 are used as indirect markers to measure neuronal activityΔFosB accumulation indicates chronic psychostimulant exposurec-Fos expression levels correlate with cancer prognosis in various tumor types

Beyond the preview

Go deeper on Immediate early gene expression, including FosB (IEG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immediate early gene expression, including FosB (IEG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call